Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.

Sector

Consumer Defensive

Industry

Packaged Foods

CEO

Li, Peiqing

Employees

2,776

Website

www.siriopharma.com

IPO Date

2019-09-25

Headquarters

No. 83, Taishan Road, Shantou, Guangdong Province, 515000, China

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Sirio Pharma 300791

Sirio Pharma Earnings Call Summary

Sirio Pharma Earnings

Transcripts

Events

About Sirio Pharma Co., Ltd.

Sirio Pharma
300791